R 129 Pill - orange round, 9mm
Pill with imprint R 129 is Orange, Round and has been identified as Clonidine Hydrochloride 0.3 mg. It is supplied by Actavis.
Clonidine is used in the treatment of ADHD; High Blood Pressure; Pain and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy. Clonidine 0.3 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for R 129
Clonidine Hydrochloride
- Imprint
- R 129
- Strength
- 0.3 mg
- Color
- Orange
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antiadrenergic agents, centrally acting
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis
- Inactive Ingredients
-
corn starch,
D&C Yellow No. 10,
FD&C Yellow No. 6,
lactose monohydrate,
magnesium stearate,
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00228-2129 | Actavis Pharma, Inc. |
| 00904-5658 (Discontinued) | Major Pharmaceuticals |
| 62584-0659 (Discontinued) | Amerisource Health Services |
Related images for "R 129"
More about clonidine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (756)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: antiadrenergic agents, centrally acting
- Breastfeeding
Patient resources
- Clonidine drug information
- Clonidine injection
- Clonidine transdermal
- Clonidine (Epidural) (Advanced Reading)
- Clonidine (Transdermal) (Advanced Reading)
Other brands
Catapres, Catapres-TTS, Kapvay, Duraclon, Nexiclon XR
Professional resources
- Clonidine monograph
- Clonidine (FDA)
- Clonidine Extended Release Tablets (FDA)
- Clonidine Injection (FDA)
- Clonidine Patch (FDA)
- Clonidine Tablets (FDA)
Other brands
Catapres, Catapres-TTS, Kapvay, Duraclon, Nexiclon XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
